For more information, go to

Release of funds

Experience to date, as for other funders, is that following our award of funding to a study it takes a considerable period of time to work through committee additional queries/requirements and engage in the detailed discussions around the interpretation of non-commercial funding guidelines in order to define the final funding model with relevant clinical research networks.

Subsequent to this, finalisation of the protocol to obtain ethical and research governance approval at the clinical sites you will be recruiting from comprises a significant part of the setup time.

Following a period of consultation (internal and external, including Clinical Trial Units) from 1st August 2011 Clinical Study grants will, as a pilot initiative, initially receive preliminary funding circa £50-100k to facilitate these activities. This will be sufficient to enable appointment of a study co-ordinator/manager (up to full time with associated costs) for up to one year to complete these tasks. The subsequent award of the full grant will be subject to such approvals for funding structure in full, ethics, research governance, drug supply etc. being in place and is not expected to be subject to additional scientific peer review.

Detailed implementation policies around Clinical Studies Subcommittee awards on this basis continue to be clarified, ultimately this enables a letter of award for this initial phase of study start up to be issued within a short period of time.  If you have any queries please contact us.

For more information, go to
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.